|
|
||||||||||
|
J Am Coll Cardiol, 1996; 27:737-750 © 1996 by the American College of Cardiology Foundation |
Division of Research, Permanente Medical Group, Inc., Oakland, California 94611, USA.
Coronary angioplasty is being increasingly used as the primary treatment for patients with acute myocardial infarction, but controversy remains over its potential adoption in preference to thrombolysis as standard care. This report summarizes the published evidence on health outcomes after primary angioplasty compared with thrombolysis or no intervention for patients with acute myocardial infarction. The data tables presented provide the scientific groundwork to assist physicians and other policy-makers in deciding which interventions to provide for broad populations of patients.
This article has been cited by other articles:
![]() |
J. HAMPTON Immediate angioplasty for the National Health Service? Heart, September 1, 2001; 86(3): 241 - 242. [Full Text] [PDF] |
||||
![]() |
P. Golino, M. Ragni, P. Cirillo, A. Scognamiglio, A. Ravera, C. Buono, A. Guarino, O. Piro, C. Lambiase, F. Botticella, et al. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1507 - H1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Keeley and W. D. Weaver Combination therapy for acute myocardial infarction J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1963 - 1965. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |